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Abstract 
A cortisol binding protein from rat liver plasma membranes has been solubilized in active form by using the zwitterionic detergent 
CHAPS. Two types of binding sites have been characterised in both native and solubilized membranes. The first is of high affinity and 
low binding capacity (12 nM; 946 fmol/mg) and the other one is of low affinity and high capacity of binding (344 nM; 12 677 fmol/mg) 
for solubilized membranes. The purified material retained a binding activity comparable to that displayed by the original membrane. The 
specific binding activity was enriched about 12700-fold, with an 8% yield. Analysis of the purified preparation on sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis showed two protein suhunits with molecular mass of 52000 and 57 000 Da. The new 
cortisol-specific binding membrane protein could be related to the nongenomic effects previously described for this hormone. 
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1. Introduction bel a plasma membrane specific protein [10]. SDS-PAGE 
showed significant R5020 binding to a 53 kDa molecule, 
It is usually assumed that steroid hormones enter the that did not occur in the presence of unlabeled R5020 100 
cell by passive diffusion, and bind cytoplasmic receptors, p~M [10]. Recent reports indicate that activation of mem- 
forming a hormone-receptor complex that translocates to brane oestrogen receptors causes a rapid release of intra- 
the nucleus and modifies the transcription of specific gene cellular calcium [11]. Moreover, glucocorticoids inhibit the 
sequences [1]. Nevertheless, it has been reported that formation of inositol phosphates in macrophages [12]. In 
steroids penetrate into the target cells by a specific trans- vascular smooth muscle and endothelial cells an increase 
port mechanism rather than by free diffusion [2,3]. in IP3 was demonstrated 15-30 s after aldosterone admin- 
Moreover, some authors have characterisedbinding sites istration. Pertussis toxin completely inhibited this re- 
in plasma membrane for oestrogens, progestins and gluco- sponse, whereas cholera toxin was without effect. These 
corticoids [4,5]. Thus, we have characterised specific bind- findings suggest he involvement of G proteins in signal 
ing sites for corticosterone in mouse [6], rat liver [7] and transduction by mineralocorticoids [13]. In the present 
kidney [8] and cortisol in mouse liver [9] plasma mem- paper, the isolation and further purification of a cortisol 
brane. Ketosteroids have been utilised successfully as binding protein from liver plasma membrane, that had not 
photoaffinity reagents for steroid receptors. The synthetic been reported so far, are described. 
steroid R5020 or promegestone was employed to photola- 
2. Materials and methods 
Abbreviations: CBG, corticosteroid binding lobulin; CHAPS, 3-[(3- 
cholamidopropyl) dimethyl-ammonia]-l-propanesulfonate; CMC, critique 2.1. Chemicals 
micellar concentration; mCBP, membrane cortisol binding protein; NAG, 
N-acetylglucosamine; PMSF, phenylmethanesulfonyl fluoride; R5020,  [3H]Cortisol (87 Ci /mmol)  was purchased from New 
17u,21-dimethyl-19-nor-pregne-4,9-diene-3,20-dione; SDS-PAGE, poly-  England Nuclear. Other steroid hormones and WGA- 
acrylamide gel electrophoresis in the presence of sodium dodecyl sup agarose were from Sigma Chemical Co. (St. Louis, MO, 
phate; WGA, wheat germ agglutinin. 
* Corresponding author. Fax: + 34 4 4648500; e-mail: USA). Hydroxyapatite r sin Biogel HTP was from Biorad. 
gbptrcom@lg.ehu.es GF /C  and GF /B  filters were obtained from Whatman. 
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PPO, bis-MSB, scintillation grade toluene and Emusolv TM tained for over 10 days at 4°C with a 20% loss (data not 
were supplied by Scharlau (Barcelona, Spain). All the shown). 
other reagents were from Merck (Darmstadt, Germany). 
2.5. Hydroxyapatite chromatography 
2.2. Isolation of liver plasma membrane 
40 mM of NazHPO 4 was added to the solubilized 
Liver plasma membrane was obtained as described with extract and applied to a 25-ml hydroxyapatite column 
slight modifications [14]. Livers from Sprague-Dawley which had been equilibrated and eluted in 40 mM 
male rats (weighting about 300 g) were perfused with Na2HPO 4, 4 mM CHAPS (pH 6.9) buffer. Eluted fraction 
NaC1 0.9%, removed and homogenised in 3 vol 0.25 M was collected by gravity and assayed as described. The 
sucrose, 20 mM Tris-HC1, 0.5 mM EDTA, 1 mM dithio- procedure was carried out in cold room. 
threitol, 0.1 mM PMSF (pH 7.4). The homogenate was 
centrifuged for 5 min at 1500 X g and the pellet was 2.6. WGA-agarose chromatography 
resuspended in the original volume and centrifuged in a 
41% (w/v)  sucrose gradient for 65 min at 95 000 X g. The Eluted fractions from hydroxyapatite were applied on a 
interracial plasma membrane fraction was washed for 25 4-ml column of WGA bound to agarose at 0.4 ml/min, 
min at 95 000 X g with TE buffer (20 mM Tris-HC1, 1.5 washed with 20 ml of a buffer 40 mM Na 2 HPO 4, 4 mM 
mM EDTA, pH 7.9) plus 140 mM NaC1 to remove CHAPS (pH 6.9). Active fractions were eluted with 10 ml 
possible adsorbed proteins. The temperature was kept at of 50 mM N-acetylglucosamine in the same buffer and 
0-40C during the isolation procedure. Purified plasma assayed as described. The procedure was carried out in 
membranes were frozen in liquid nitrogen and stored in cold room. 
homogenisation buffer at -70°C. The purity of this frac- 
tion has been previously determined with marker proteins 2.7. High resolution size-exclusion chromatography 
[7]. 
Active fractions from WGA-agarose chromatography 
2.3. Cortisol binding assays were pooled and concentrated with a ultrafiltration device 
(Centriprep 10 Amicon) from 10 ml to 600 ILl. 200-400 
The standard mixture contained 20 mM Tris-HC1, 0.5 txl of samples were applied on a ProteinPack SW300 glass 
mM EDTA (pH 7.9), a sample, 10 nM [3H]cortisol in a 1 column (Waters) (300 X 8 mm) in a Smart micro purifica- 
ml total volume. Incubation was performed at 4°C for 45 tion system (Pharmacia) at room temperature. Chromatog- 
min and terminated by the addition of 4 ml of cold 20 mM raphy was performed at a flow rate of 0.3 ml /min with 
Tris-HC1, 0.5 mM EDTA (pH 7.9). The mixture was then buffer 20 mM Tris-HC1, 1.5 mM EDTA, 100 mM NaC1, 
filtered in vacuum through a GF /B  filter, pre-soaked with 10% glycerol, 6 mM CHAPS (pH 7). 250-pA fractions 
0.3% polyethylenimine (PEI) for 4 h [15]. The filter was were collected and aliquots assayed as described in Section 
washed two times with 4 ml of the same buffer. When 2.3. 
membrane samples were assayed, it was carried out in the 
same way but filtered directly on GF /C  filters without PEI 2.8. High resolution ionic exchange chromatography 
treatment [7]. 
It was carried out in a Smart system at room tempera- 
2.4. Solubilization ture. A 100-1xl mono-Q column (1.65 >< 50 mm) was 
equilibrated with buffer 20 mM piperazine, 10% glycerol, 
Non-ionic (Brij 35, octylglucoside, Triton X- 100, Tween 8 mM CHAPS (pH 5). Pooled active fractions (1 ml) from 
20) and zwitterionic (CHAPS) detergents were examined the previous tep were applied at 50 ixl/min. The column 
for their capacity to solubilize the [3H]cortisol binding was washed with 1 ml of buffer and the protein eluted with 
activity from plasma membrane. All detergents ested solu- a NaCI gradient with three isocratic steps at 100, 160 and 
bilize 40-60% of the binding activity. CHAPS was se- 200 mM. Fractions of 100 t~1 were collected and aliquots 
lected because of its high CMC and little interference with assayed as described in Section 2.3. 
the assays. Moreover, CHAPS has been used to isolate a 
number of receptor proteins in their active form. Liver 2.9. SDS-polyacrylamide g l electrophoresis 
plasma membrane fraction (about 4 mg protein/ml), con- 
taining 0.1 mM PMSF was stirred with 6 mM CHAPS for Protein samples were precipitated by the addition of 
15 min at 4°C. The mixture was centrifuged at 100000 × g t0% trichloroacetic acid, centrifuged at 14000 X g 15 min 
for 60 min. The supernatant was recovered as the solubi- and washed twice with acetone as described [16]. The 
lized extract. Thus CHAPS solubilize 60% of the mem- precipitates were dissolved in 40 txl of Laemmli buffer and 
brane steroid binding protein and the active form is main- subjected to electrophoresis n a 12.5% gel. Molecular 
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Fig. 1. Part A: Scatchard-analysis of the specific binding of [3H]cortisol to rat liver plasma membranes as a function of radioactive steroid concentration 
(0.5-80 nM). Two sets of incubation were carried out simultaneously with the same plasma membranes fraction (0.2 mg/ml  of protein) in the presence 
and absence of 10 IxM cortisol for 60 rain at 2°C in Tris buffer (pH 7.9). Part B: Scatchard plot of the specific binding data obtained in the same conditions 
from hepatic plasma membranes solubilized with 6 mM CHAPS. Points indicate the mean + S.E.M. of quadruplicate determinations. B, [3H]cortisol bound 
( fmol/mg protein); F, [3H]cortisol free (nM). 
weight determination was performed using the following proteins. The kinetic parameters determined were: equilib- 
standard proteins: [3-galactosidase (116 kDa), phosphory- rium dissociation constant 12 + 3 and 344 ___ 31 nM, and 
lase b (97.4 kDa), BSA (66 kDa), ovalbumin (45 kDa) and maximal binding capacity 946 ± 97 and 12677 + 1160 
carbonic anhydrase (29 kDa). Proteins were silver stained fmol/mg protein for the high and low affinity binding 
according to the Bio-Rad kit method, sites respectively (Fig. 1B). The Hill coefficient calculated 
from the binding data were 1.058 (from native) and 0.949 
2.10. Protein assays (from solubilized membranes). We can infer that there are 
not cooperativity in both binding process. The binding 
Proteins were determined according to Bradford [17] characterised in native and solubilized membranes show a 
with the Bio-Rad protein assay kit, using BSA as reference heterogeneous population of sites. 
standard. In the last purification step, the protein concen- The kinetic parameters determined for high affinity 
tration was calculated from absorbance at280 nm, calibrat- binding sites in native and solubilized membrane are simi- 
ing with a known amount of protein, lar to that obtained by us and other authors with different 
corticoids and plasma membranes [6-9,18-20]. In order to 
3. Results characterise cortisol binding to rat liver plasma membrane, 
we checked the ability of different steroids to compete for 
3.1. Cortisol binding assays the cortisol binding protein. The displacement of 4 nM 
[3H]cortisol bound to rat liver plasma membrane high 
Two types of binding sites have been characterised in affinity binding site was carried out in the presence of 
rat plasma membrane. The first is of high affinity and low increasing concentrations of unlabeled steroids. Their 
binding capacity (5 + 1 nM and 1088 5:76 fmol/mg pro- affinities vary in the following order: cortisol, pred- 
tein) and the other one is of low affinity and high binding nisolone, 1 ll3-hydroxyprogesterone, progesterone, deoxy- 
capacity (155 _+ 12 nM and 13976 _+ 1258 fmol/mg pro- cort icosterone,  cor t icosterone > 1 1 et -hydroxy-  
tein) (Fig. 1A). Scatchard-analysis of binding site data in progesterone > 20e~-hydroxyprogesterone > 20[3-hydroxy- 
the membrane solubilized by 6 mM CHAPS also showed progesterone  > a ldosterone  > tes tos terone  >
the existence of two different and independent binding dexamethasone > triamcinolone acetonide (data not 
Table 1 
Purification of the cortisol binding protein (mCBP) from rat liver plasma membrane 
Protein Volume Total Prot. Spec. Act. Total Act. Recovery Purification 
(p,g/ml) (ml) (p,g) (fmol/Izg) (fmol) (%) (fold) 
Membrane 4440 50 222000 0.6 123913 - - 
Supernatant 3427 45 154215 0.4 62586 100.0 1 
Hydroxyapatite 110 50 5500 9.0 49585 79.7 22 
WGA-agarose 20 10 200 90.7 18138 29.0 223 
TSK300 7 1.5 10 1569.8 16483 26.3 3867 
Mono-Q 2.5 0.4 1 a 5172.0 5172 8.3 12739 
a Final protein concentration obtained by the integration of the Az80 peak area. 
For more methodological details see Section 2. 
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Fig. 2. WGA-agarose chromatography, mCBP-containing fractions eluted VOLUME (ml) 
from the hydroxyapatite column were applied on a column of WGA- 
agarose at 0.4 ml/min. Active fractions were eluted with 10 ml of 50 Fig. 4. Anion exchange chromatography. Pooled active fractions from the 
mM NAG in the same buffer. Chromatography was performed as de- size-exclusion chromatography were injected on a Mono-Q TM column 
scribed in Section 2.6 and the aliquots binding activity were displayed. (1.6 × 50 mm) equilibrated with buffer 20 mM piperazine, 10% glycerol, 
8 mM CHAPS (pH 5) at 50 I.~I/min in a Smart System (Pharmacia), 
Chromatography was performed as described in Section 2.8. Absorbance 
shown). We can deduce that the high specific binding site 280 nm (broken line) and the aliquots binding activity (shaded area) were 
observed is not the glucocorticoid cytosolic receptor, in represented. 
view of the affinities that dexamethasone and triamci- 
nolone acetonide have to that receptor [21]. The binding 
does not occur on the progesterone cytosolic receptor 223-fold purification. The NAG active fractions are con- 
either, because the latter does not bind cortisol nor cortico- centrated and subjected to size-exclusion chromatography. 
sterone. Also, the low affinity for aldosterone of the The elution profile is shown in Fig. 3. Glycerol is added to 
plasma membrane binding site allows to differentiate it the buffer in order to improve recovery [22]. The binding 
from the glucocorticoid type-I receptor. 
3.2. Purification of the membrane cortisol binding protein 
(mCBP) 
First, the solubilized extract is subjected to hydroxy- 
apatite chromatography (Table 1). The eluate usually con- 
tains 80-90% of the [3H]cortisol binding activity and only 
about 5% of the initial protein. About 22-fold purification 
is achieved in this first step. This eluate is adsorbed onto 
WGA-agarose and the binding activity released by addi- 
tion of 50 mM NAG (Fig. 2). This second step reaches 
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VOLUME (ml) Fig. 5. SDS-polyacrylamide g l electrophoresis of purified mCBP. Pro- 
Fig. 3. Size-exclusion chromatography. Active fractions from WGA- tein samples were dissolved in 40 I~1 solubilization buffer (3% SDS, 10% 
agarose chromatography were pooled and concentrated with an ultrafihra- glycerol, 20 mM Tris, 0.01% bromophenol b ue) and subjected to elec- 
tion device [Centriprep 10 Amicon]. A 400-~1 sample of the mCBP trophoresis n a 12.5% polyacrylamide g l. Lane A, active fractions from 
containing fractions was applied on a Protein Pack SW300 glass column Mono-Q TM column. Lane B, molecular weight markers: 1.13-galactosidase 
(Waters) (300×8 mm) in a Smart System (Pharmacia). Chromatography (116 kDa), 2. phosphorylase b (97.4 kDa), 3. BSA (66 kDa), 4. ovalbu- 
was performed as described in Section 2.7. Absorbance 280 nm (broken min (45 kDa), and 5. carbonic anhydrase (29 kDa). Electrophoresis was 
line) and the aliquots binding activity (shaded area) were represented, performed as described in Section 2.9. 
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activity is eluted in a symmetrical peak at around 8.5 ml The first phase, hydroxyapatite chromatography, was a 
retention volume. This corresponds to a protein of molecu- critical step decreasing the total protein amount with high 
lar mass of 120 kDa (according to molecular weight recovery. The fact that this protein adsorbs to WGA- 
markers). The major impurity elutes at 9 ml. A 3867-fold agarose and can be eluted with NAG suggested that mCBP 
purifcation is attained after this step. The last step of could be a glycoprotein as most membrane r ceptors are. If 
purification is carried out in an optimised system for a molecular weight of 55 000 for this protein band and one 
protein micropurification (Smart System) with a mono-Q ligand site per molecule are assumed, the final specific 
PC 1.6/50 mm column. The buffer is piperazine pH 5 and activity was about 50% of the theoretical value. Since 
a higher CHAPS concentration (8 mM) is used to improve quantitative binding of the ligand was in all probability not 
resolution. In addition, the gradient has three isocratic obtained, one would expect hat the purified material was 
steps to better resolve the different peaks. The active essentially homogeneous and that the specific activity 
fractions are obtained at 200 mM NaC1 (Fig. 4) with a smaller than the theoretical one was due to denaturation of
final purification of 12 700-fold over the solubilized extract some of the hormone binding sites. The two different 
(Table 1). The silver-stained SDS-PAGE gel (Fig. 5) shows bands, to 52 and 57 kDa, could be due to the existence of a 
two main bands of m 52 and 57 kDa. A representative heterodimer with a native M r of 110000. This last value 
purification of mCBP is shown in Table 1. About 12700- was the size-exclusion m obtained, but we can think of a 
fold purification is obtained from the solubilized extract possible hydrodynamic change produced by the binding of 
with a recovery of 8%. According to Table 1, the specific detergent molecules on a hydrophobic membrane protein. 
activity reached (5172 fmol/ixg protein) is about 50% of It is also known that sugars in glycoproteins greatly in- 
the theoretical maximum activity that could be obtained crease the Stokes radius. On the other hand, we can also 
from the binding of one mol of [3H]cortisol to one mol of deduce that these two bands could correspond with the two 
55 kDa protein. These results guarantee the preparation different ypes of binding proteins characterised, one of 
purity, high and another one of low affinity for cortisol. 
Some characteristics of this mCBP remind those of the 
serum steroid carrier, CBG or transcortin. In addition, 
4. Discussion some authors have described this membrane steroid bind- 
ing protein as a transcortin-like protein. An alternative 
The presence of specific steroid binding to plasma possibility was the plausible existence of two different 
membranes has been reported by different authors [23-25]. types of CBG molecules: a soluble one in plasma and a 
Previous work from our laboratory shows the existence of second one anchored to the plasma membrane. These two 
specific steroid binding to plasma membranes [6-9]. In kinds of proteins exist in the cases of IgM, insulin recep- 
this study the cortisol binding to rat hepatic native and tor, HLA antigens, interleukin-2 receptor and transferrin 
solubilized plasma membranes has been characterised and [29]. However, the negative results with anti-CBG antibod- 
the kinetic properties are similar to those determined previ- ies, both in ELISA and Western blot techniques (data not 
ously, shown), rather suggest hat the membrane steroid binding 
We also had characterised by [3H]R5020 photoaffinity protein and the corticosteroid binding globulin are unre- 
labelling the presence of a 53 kDa protein, that binds lated proteins. Therefore, this new membrane cortisol bind- 
R5020 specifically [10]. In order to determine the analogy ing protein could be related to the rapid effects of gluco- 
of the purified R5020 binding protein, photolabelling ex- corticoids on liver glycogen metabolism [30] and others 
periments were carried out with [3H]R5020. We found that nongenomic responses [31]. Recently, Sze and Iqbal [32] 
R5020 binds a different protein from cortisol, with similar have reported the modulation by glucocorticoids of 
molecular weight, in base to the different size exclusion [~25I]calmodulin binding in synaptic plasma membranes. 
chromatography elution profile and autoradiographic re- The present work about the purification of a cortisol 
sults, binding protein from hepatic plasma membrane will allow 
Other authors have investigated the identity of mem- in the future the micro sequencing and cloning of gene that 
brahe steroid binding protein in different systems. Ga- codified this protein. 
metchu et al. [26], labelling S-49 lymphoma cells with 
dexamethasone-21-mesylate, found multiple bands with 
molecular mass 170-500 kDa. A 50 kDa protein was 
labelled with [J25I]aldosterone in mononuclear leukocytes Acknowledgements 
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